mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.2 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |